Warning letter
Bon Secours Health System Incorporated: warning letter of Dec 10, 2001
FDA warning letter UCM178217 · Baltimore District Office
Key facts
| Reference number | UCM178217 |
|---|---|
| Company | Bon Secours Health System Incorporated |
| Subject | Current Good Manufacturing Practice Regulations for Medical Gases |
| Issue date | Dec 10, 2001 |
| Posted date | Dec 10, 2001 |
| Issuing office | Baltimore District Office |
| Product type | Unknown |
| CFR sections cited | 211.150, 211, 211.22, 211.165 |
| Country | 3 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: